Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
A Phase 1 Dose Escalation Study Evaluating the Safety and Tolerability of PF-06840003 in Patients with Malignant Glioma
Clinical Trial Grant
Duke Scholars
Principal Investigator
Annick Desjardins
Neurosurgery, Neuro-Oncology
Awarded By
Pfizer, Inc.
Start Date
September 1, 2016
End Date
July 15, 2020
Awarded By
Pfizer, Inc.
Start Date
September 1, 2016
End Date
July 15, 2020
